Back to Search
Start Over
Identification of metabolomic profile related to adult Fontan pathophysiology.
- Source :
-
International journal of cardiology. Heart & vasculature [Int J Cardiol Heart Vasc] 2021 Nov 24; Vol. 37, pp. 100921. Date of Electronic Publication: 2021 Nov 24 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Background: Metabolic disorders are important pathophysiologies that can cause multiple organ dysfunction and worsen prognosis in Fontan patients. This study aimed to comprehensively evaluate the metabolomic profile of adult Fontan patients and characterize its pathophysiology in relation to 2 control groups.<br />Methods and Results: We performed metabolomic analysis of 31 plasma samples using capillary electrophoresis time-of-flight mass spectrometry. This observational cross-sectional study compared plasma metabolites of 14 heterogeneous adult Fontan patients with those of control groups, including 9 patients with congenital heart disease after biventricular repair and 8 normal healthy controls. Fontan patients exhibited significant differences in intermediate metabolite concentrations related to glycolysis, the tricarboxylic acid (TCA) cycle, and the urea cycle. The plasma concentrations of lactic acid, 2-oxoglutarate, isocitric acid, malic acid, cis -aconitic acid, arginine, citrulline, and the ratio of ornithine/citrulline showed significantly differences among the groups. Multiple logistic regression analysis with a stepwise selection-elimination method identified 2-oxoglutaric acid (odds ratio [OR] 1.98, 95% confidence interval [CI] 1.05-3.76) and cis -aconitic acid (OR 2.69, 95% CI 1.04-6.99) as independently associated with Fontan patients. After adjustment for the covariates of age and gender, 2-oxoglutaric acid (OR 1.97, 95% CI 0.98-3.93) and cis -aconitic acid (OR 3.88, 95% CI 0.99-15.2) showed remarkable relationships with Fontan patients.<br />Conclusions: The present findings suggest that abnormalities in the TCA cycle and amino acid metabolism are distinguishing features in the pathophysiology of Fontan patients. Future metabolomic studies will assist in developing biomarkers for the early prediction of "silent" Fontan pathophysiologies.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2021 The Authors.)
Details
- Language :
- English
- ISSN :
- 2352-9067
- Volume :
- 37
- Database :
- MEDLINE
- Journal :
- International journal of cardiology. Heart & vasculature
- Publication Type :
- Academic Journal
- Accession number :
- 34901379
- Full Text :
- https://doi.org/10.1016/j.ijcha.2021.100921